Local Suicide Risk Factors; Chappell Roan’s Bipolar II Disorder; Student Mindfulness

—
News and commentary from the psychiatry world

by
Kristen Monaco, Senior Staff Writer, MedPage Today
September 11, 2024

Local economic and social conditions like health insurance access, internet, and household income, were tied with suicide risk, according to a new CDC report.

The FDA cleared DeepWell Digital Therapeutics’ technology that can be integrated or adjacent to immersive media for the treatment of stress and hypertension.

Singer Chappell Roan, who has bipolar II disorder, said her recent surge in fame triggered a hypomania episode. (Rolling Stone)

Suicide rates haven’t slowed, despite federal efforts to prevent it. (CBS News)

In other news, a Native American-led suicide prevention program in Alaska is trying a community-building approach to the problem. (NPR)

An increase in amygdala reactivity after stopping antidepressants was tied with relapse risk and may serve as a functional neuroimaging marker, said researchers in JAMA Psychiatry.

A 32-year-old first-year psychiatry resident at UC Davis died after she was hit by a vehicle while riding an electric scooter. (CBS News)

CDC data from 2022 found rates of health center visits were much higher for people with mental health disorders only than it was for people with substance use disorders only or a combination of the two.

The serotonin-norepinephrine reuptake inhibitor venlafaxine (Effexor) was no better than placebo for reducing vertigo episodes in Meniere disease. (JAMA Otolaryngology Head & Neck Surgery)

The Biden administration issued a final rule to improve access to mental health and substance abuse care. (Reuters)

A 41-study review found three mindfulness interventions — Learning to BREATHE, Mindfulness in School Project, and mindfulness-based stress reduction — were backed by a high level of evidence to promote student well-being and prevent mental health conditions. (Psychiatric Services)

Britain’s healthcare regulator cleared GLP-1 agents of being linked with suicidal thoughts, in line with conclusions from a European regulatory review and preliminary findings from the FDA.